ERBB2 and breast carcinoma: Depending on the number of biological markers (proteins associated with mechanisms underlying the disease), most studies divide breast cancer into four major molecular subtypes: luminal A, luminal B, triple negative/basal-like (TN), and HER2 over-expression (approximate prevalences of, respectively, 40%, 20%, 20%, and 15%).